Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adrenal Gland Pheochromocytoma
|
50 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.040 | 1.000 | 4 | 1997 | 2019 | |||||
C-cell hyperplasia of thyroid
|
16 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Constipation
|
57 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.700 | 0 | ||||||||
Familial medullary thyroid carcinoma
|
45 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.770 | 1.000 | 7 | 1996 | 2018 | |||||
Ganglioneuromatosis
|
1 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 1999 | 1999 | |||||
Gastrointestinal symptom
|
7 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 1998 | 1998 | |||||
Gingival Overgrowth
|
5 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.700 | 0 | ||||||||
Hirschsprung Disease
|
162 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 1999 | 2009 | |||||
Hyperparathyroidism, Primary
|
39 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Hypothyroidism
|
283 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.700 | 0 | ||||||||
Malignant neoplasm of thyroid
|
103 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2015 | 2018 | |||||
Malignant Neoplasms
|
1641 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Medullary carcinoma of thyroid
|
71 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.800 | 1.000 | 26 | 1996 | 2018 | |||||
Multiple Endocrine Neoplasia
|
11 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Multiple Endocrine Neoplasia Type 1
|
156 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 1995 | 1995 | |||||
Multiple endocrine neoplasia Type 2
|
38 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.700 | 1.000 | 8 | 1994 | 2016 | |||||
Multiple Endocrine Neoplasia Type 2a
|
44 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.720 | 1.000 | 7 | 1995 | 2011 | |||||
Multiple Endocrine Neoplasia Type 2b
|
21 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.900 | 0.974 | 38 | 1994 | 2019 | |||||
Multiple Endocrine Neoplasia, Type IV
|
23 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 1995 | 1995 | |||||
Neoplasms
|
1644 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.090 | 1.000 | 9 | 2001 | 2018 | |||||
Orbital separation excessive
|
77 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.700 | 0 | ||||||||
Papillary thyroid carcinoma
|
204 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Pheochromocytoma
|
186 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.740 | 1.000 | 4 | 1997 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Range of joint movement increased
|
46 | 0.662 | 0.280 | 10 | 43121968 | missense variant | T/C | snv | 4.0E-06 | 0.700 | 0 |